An Open Label Safety Study of Tipranavir Co-administered With Low-dose Ritonavir in Patients With Advanced HIV-1 Infection and Limited Treatment Options.
Expanded access is no longer available for this treatment.
Information provided by:
First received: July 3, 2009
Last updated: October 30, 2013
Last verified: October 2013
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||Expanded access is no longer available for this treatment.|
|Estimated Study Completion Date:||No date given|
|Primary Completion Date:||June 2008 (Final data collection date for primary outcome measure)|